1. Introduction:

  Lyme disease is an emerging tick-borne spirochetal infection.Based on the different genospecies of Borrelia spirochetes, human infection may cause multisystem disorders with varying degrees of clinical symptoms, ranging from a relatively benign skin lesion to severe arthritic, neurological and cardiac illness. Therefore, Lyme disease is currently considered the most important vector-borne human infections in Europe and the United States. Since 2002, Lyme disease had also been included as the Category 4 Notifiable Diseases in Taiwan. In 1998, we report herein the first laboratory-diagnosed human case of Lyme disease in Taiwan. B. burgdorferi sensu stricto, a genospecies firstly identified in Asia (Shih et al., 1998; Shih and Chao, 2002). In addition, the Lyme disease spirochetes (B. burgdorferi sensu lato) had also been isolated from human, rodent hosts and vector ticks, and all these Taiwan isolates were genetically classified into three genospecies (i.e., B. burgdorferi sensu stricto, B. garinii, and B. afzelii). Although the serological prevalence of human and reservoir animals had been reported in Taiwan.Since 2015, we have established the first serodiagnostic platform for Lyme disease infection in KMU that can provide the standard diagnosis for screening the Borrelia burgdorferi-associated infection in KMU.


2. Service items:

  • Serodiagnostic test of Lyme disease (IFA test & Western blot test)
  • Cultivation of Lyme disease spirochetes (Borrelia burgdorferi sensu lato)


3. Charges:



Contact person:Chien-ming Shih


Go to top